Fas ligand-induced apoptosis of hepatocytes in natural killer cell leukaemia

被引:7
作者
Tani, R
Ozaki, S
Kosaka, M
Fujiwara, S
Shibata, H
Wakatsuki, S
Matsumoto, T
机构
[1] Univ Tokushima, Sch Med, Dept Internal Med 1, Tokushima 7708503, Japan
[2] Univ Tokushima, Sch Med, Dept Pathol 1, Tokushima 7708503, Japan
关键词
natural killer cell; Fas; Fas ligand; apoptosis; liver;
D O I
10.1046/j.1365-2141.1999.01594.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Neoplastic natural killer (NK) cells overexpress Pas ligand (FasL), which may cause damage of Pas-bearing tissues. We report a patient with NK cell leukaemia who developed liver injury after pharyngitis. The NK leukaemic cells expressed functional Fast. In addition to soluble Fast, serum levels of interleukin-6 and interferon-gamma were increased dramatically when liver injury was aggravated. Moreover, hepatocytes expressed Fas and apoptotic hepatocytes were detected in the portal areas. These findings are consistent with the notion that inflammatory cytokines enhance the sensitivity to Fast and trigger apoptosis of hepatocytes in NK cell malignancies.
引用
收藏
页码:709 / 712
页数:4
相关论文
共 10 条
[1]   AGGRESSIVE NATURAL-KILLER-CELL LEUKEMIA LYMPHOMA - REPORT OF 4 CASES AND REVIEW OF THE LITERATURE - POSSIBLE EXISTENCE OF A NEW CLINICAL ENTITY ORIGINATING FROM THE 3RD LINEAGE OF LYMPHOID-CELLS [J].
IMAMURA, N ;
KUSUNOKI, Y ;
KAWAHA, K ;
YUMURA, K ;
HARA, J ;
ODA, K ;
ABE, K ;
DOHY, H ;
INADA, T ;
KAJIHARA, H ;
KURAMOTO, A .
BRITISH JOURNAL OF HAEMATOLOGY, 1990, 75 (01) :49-59
[2]   Elevated serum soluble Fas ligand in natural killer cell proliferative disorders [J].
Kato, K ;
Ohshima, K ;
Ishihara, S ;
Anzai, K ;
Suzumiya, J ;
Kikuchi, M .
BRITISH JOURNAL OF HAEMATOLOGY, 1998, 103 (04) :1164-1166
[3]  
LEITHAUSER F, 1993, LAB INVEST, V69, P415
[4]   FAS ANTIGEN EXPRESSION ON CD34(+) HUMAN MARROW-CELLS IS INDUCED BY INTERFERON-GAMMA AND TUMOR-NECROSIS-FACTOR-ALPHA AND POTENTIATES CYTOKINE-MEDIATED HEMATOPOIETIC SUPPRESSION IN-VITRO [J].
MACIEJEWSKI, J ;
SELLERI, C ;
ANDERSON, S ;
YOUNG, NS .
BLOOD, 1995, 85 (11) :3183-3190
[5]   Constitutive expression of Fas ligand in large granular lymphocyte leukaemia [J].
Perzova, R ;
Loughran, TP .
BRITISH JOURNAL OF HAEMATOLOGY, 1997, 97 (01) :123-126
[6]   An aggressive nasal lymphoma accompanied by high levels of soluble Fas ligand [J].
Sato, K ;
Kimura, F ;
Nakamura, Y ;
Murakami, H ;
Yoshida, M ;
Tanaka, M ;
Nagata, S ;
Kanatani, Y ;
Wakimoto, N ;
Nagata, N ;
Motoyoshi, K .
BRITISH JOURNAL OF HAEMATOLOGY, 1996, 94 (02) :379-382
[7]  
Tanaka M, 1997, J IMMUNOL, V158, P2303
[8]   Downregulation of Fas ligand by shedding [J].
Tanaka, M ;
Itai, T ;
Adachi, M ;
Nagata, S .
NATURE MEDICINE, 1998, 4 (01) :31-36
[9]   Fas ligand in human serum [J].
Tanaka, M ;
Suda, T ;
Haze, K ;
Nakamura, N ;
Sato, K ;
Kimura, F ;
Motoyoshi, K ;
Mizuki, M ;
Tagawa, S ;
Ohga, S ;
Hatake, K ;
Drummond, AH ;
Nagata, S .
NATURE MEDICINE, 1996, 2 (03) :317-322
[10]   Expression of Fas and anti-Fas-mediated apoptosis in human hepatocellular carcinoma cell lines [J].
Yano, H ;
Fukuda, K ;
Haramaki, M ;
Momosaki, S ;
Ogasawara, S ;
Higaki, K ;
Kojiro, M .
JOURNAL OF HEPATOLOGY, 1996, 25 (04) :454-464